Exagen Inc.
XGN • NASDAQ
Exagen Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO John Aballi, with a market cap of $74.3M.
Market Cap$74.3M
Employees179.0
CEOJohn Aballi
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 4, 2026 · In 3 weeksQ1 2026
Financials
Exagen Inc. FAQ
Common questions about Exagen Inc.
Exagen Inc. is scheduled to report earnings for Q1 2026 on May 4, 2026. Analysts estimate revenue of $16.6M.
Exagen Inc. has approximately 179 employees.